| 產(chǎn)品名稱 |
HCC1806 |
| 商品貨號(hào) |
B164565 |
| Organism |
Homo sapiens, human |
| Tissue |
mammary gland; breast |
| Cell Type |
Epithelial |
| Product Format |
frozen |
| Morphology |
epithelial |
| Culture Properties |
adherent, The line grows as attached medium-sized epithelial cells without floating cells. |
| Biosafety Level |
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease |
TNM stage IIB, grade 2, primary acantholytic squamous cell carcinoma |
| Age |
60 years |
| Gender |
female |
| Ethnicity |
Black |
| Karyotype |
Number of cells examined = 59; Modal Chromosome Number = 75 with a range of 65 to 79; Polyploidy Rate = 22% |
| Derivation |
The HCC1806 breast cancer cell line was initiated on July 31, 1995, and took 10 months to establish. |
| Clinical Data |
60 years Black female |
| Receptor Expression |
estrogen receptor, negative progesterone receptor, negative |
| Oncogene |
her2/neu -, p53 - |
| Genes Expressed |
Epithelial glycoprotein 2 [EGP2]; cytokeratin 19 |
| Cellular Products |
Epithelial glycoprotein 2 [EGP2]; cytokeratin 19 |
| Comments |
The tumor was classified as a TNM Stage IIB, grade 2, acantholytic squamous carcinoma with no lymph node metastasis.
There was no family history of breast cancer.
The cells are poorly differentiated.
The cells are negative for expression of Her2-neu and for expression of p53.
HCC1806 is positive for the epithelial cell specific marker Epithelial Glycoprotein 2 (EGP2) and for cytokeratin 19.
The cells are negative for expression of estrogen receptor (ER) and for expression of progesterone receptor (PR).
The cells are homozygous for deletions in the FHIT gene at 3p14.2.
|
| Complete Growth Medium |
The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, ATCC 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum (ATCC 30-2020) to a final concentration of 10%.
|
| Subculturing |
Volumes used in this protocol are for 75 cm2 flask; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes.
- Remove and discard culture medium.
- Briefly rinse the cell layer with 0.25% (w/v) Trypsin-0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
- Add 2.0 to 3.0 mL of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.
- Add 6.0 to 8.0 mL of complete growth medium and aspirate cells by gently pipetting.
- Add appropriate aliquots of the cell suspension to new culture vessels.
- Incubate cultures at 37°C
Subculture Ratio: 1:2 to 1:4
Medium Renewal: Every 2 to 3 days.
Note: For more information on enzymatic dissociation and subculturing of cell lines consult Chapter 10 in Culture of Animal Cells, a manual of Basic Technique by R. Ian Freshney, 3rd edition, published by Alan R. Liss, N.Y., 1994.
|
| Cryopreservation |
Culture medium, 95%; DMSO, 5% |
| Culture Conditions |
Temperature: 37°C |
| STR Profile |
D5S818: 13
D13S317: 11
D7S820: 10, 12
D16S539: 10
vWA: 16, 18
TH01: 8
Amelogenin: X
TPOX: 8, 9
CSF1PO: 12 |
| Name of Depositor |
AF Gazdar, AK Virmani |
| References |
Ahmadian M, et al. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands. Cancer Res. 57: 3664-3668, 1997. PubMed: 9288768
Gazdar AF, et al. Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer. Int. J. Cancer 78: 766-774, 1998. PubMed: 9833771
|
